China NMPA Product Recall - Drug infusion system
China NMPA product recall for Drug infusion system by Medtronic Inc. published January 10, 2020. Recall level: Level 3 Recall. Medtronic Inc., through its Medtronic (Shanghai) Management Co., Ltd. entity, initiated a voluntary
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Drug infusion system by Medtronic Inc. published January 10, 2020. Recall level: Level 3 Recall. Medtronic Inc., through its Medtronic (Shanghai) Management Co., Ltd. entity, initiated a voluntary
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Medtronic Inc.Inspection Date
Unknown Date
Product Type
ID: dab0deb7-18f8-416a-8b72-379f6cfbbc62
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox